IL289210A - Method for the production of an antibody - Google Patents

Method for the production of an antibody

Info

Publication number
IL289210A
IL289210A IL289210A IL28921021A IL289210A IL 289210 A IL289210 A IL 289210A IL 289210 A IL289210 A IL 289210A IL 28921021 A IL28921021 A IL 28921021A IL 289210 A IL289210 A IL 289210A
Authority
IL
Israel
Prior art keywords
antibody
producing
Prior art date
Application number
IL289210A
Other languages
English (en)
Hebrew (he)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL289210A publication Critical patent/IL289210A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2820/00—Vectors comprising a special origin of replication system
    • C12N2820/60—Vectors comprising a special origin of replication system from viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL289210A 2019-06-28 2021-12-21 Method for the production of an antibody IL289210A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19183171 2019-06-28
PCT/EP2020/067770 WO2020260431A1 (en) 2019-06-28 2020-06-25 Method for the production of an antibody

Publications (1)

Publication Number Publication Date
IL289210A true IL289210A (en) 2022-02-01

Family

ID=67253661

Family Applications (1)

Application Number Title Priority Date Filing Date
IL289210A IL289210A (en) 2019-06-28 2021-12-21 Method for the production of an antibody

Country Status (11)

Country Link
US (1) US20220220500A1 (cg-RX-API-DMAC7.html)
EP (1) EP3990484A1 (cg-RX-API-DMAC7.html)
JP (2) JP7511591B2 (cg-RX-API-DMAC7.html)
KR (1) KR102900433B1 (cg-RX-API-DMAC7.html)
CN (1) CN113993888B (cg-RX-API-DMAC7.html)
AU (1) AU2020304841B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021025806A2 (cg-RX-API-DMAC7.html)
CA (1) CA3143803A1 (cg-RX-API-DMAC7.html)
IL (1) IL289210A (cg-RX-API-DMAC7.html)
MX (1) MX2021015193A (cg-RX-API-DMAC7.html)
WO (1) WO2020260431A1 (cg-RX-API-DMAC7.html)

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JP3101690B2 (ja) 1987-03-18 2000-10-23 エス・ビィ・2・インコーポレイテッド 変性抗体の、または変性抗体に関する改良
US5010182A (en) 1987-07-28 1991-04-23 Chiron Corporation DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
AU4005289A (en) 1988-08-25 1990-03-01 Smithkline Beecham Corporation Recombinant saccharomyces
US5082767A (en) 1989-02-27 1992-01-21 Hatfield G Wesley Codon pair utilization
US5959177A (en) 1989-10-27 1999-09-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
US5795737A (en) 1994-09-19 1998-08-18 The General Hospital Corporation High level expression of proteins
US6040498A (en) 1998-08-11 2000-03-21 North Caroline State University Genetically engineered duckweed
US7125978B1 (en) 1999-10-04 2006-10-24 Medicago Inc. Promoter for regulating expression of foreign genes
KR100797667B1 (ko) 1999-10-04 2008-01-23 메디카고 인코포레이티드 외래 유전자의 전사를 조절하는 방법
JP2006238894A (ja) * 2000-02-15 2006-09-14 Amgen Inc 線維芽細胞成長因子−23分子およびその使用
ATE318908T1 (de) 2000-05-18 2006-03-15 Geneart Gmbh Synthetische gene für gagpol und deren verwendungen
US7879540B1 (en) 2000-08-24 2011-02-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
WO2003070957A2 (en) 2002-02-20 2003-08-28 Novozymes A/S Plant polypeptide production
EP1490494A1 (en) 2002-04-01 2004-12-29 Walter Reed Army Institute of Research Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell
JP5331340B2 (ja) 2004-05-18 2013-10-30 バイカル インコーポレイテッド インフルエンザウィルスワクチン組成物、及びその使用方法
EA200700751A1 (ru) * 2004-10-05 2008-06-30 Элан Фарма Интернэшнл Лимитед Способы и композиции для улучшения продуцирования рекомбинантного белка
KR20090018799A (ko) 2006-05-30 2009-02-23 다우 글로벌 테크놀로지스 인크. 코돈 최적화 방법
CA2657975A1 (en) 2006-06-29 2008-01-03 Dsm Ip Assets B.V. A method for achieving improved polypeptide expression
KR101163295B1 (ko) * 2007-06-29 2012-07-05 에프. 호프만-라 로슈 아게 향상된 면역글로불린을 생산하는 중쇄 돌연변이체
WO2009059235A2 (en) * 2007-11-01 2009-05-07 Facet Biotech Corporation Immunoglobulin display vectors
JP2012508563A (ja) * 2008-11-12 2012-04-12 シェーリング コーポレイション 抗IGF1R発現の増強のためのβGl−IGGイントロン
US20100303776A1 (en) * 2009-04-16 2010-12-02 The University Of North Carolina At Chapel Hill Methods and compositions for regulated expression of multiple nucleic acids
KR20130013435A (ko) 2011-07-28 2013-02-06 차의과학대학교 산학협력단 태반-유래 줄기세포의 증식방법
RU2612910C2 (ru) * 2011-12-21 2017-03-13 Ф. Хоффманн-Ля Рош Аг Быстрый способ клонирования и экспрессии сегментов гена родственной вариабельной области антитела
CN107881196A (zh) * 2011-12-22 2018-04-06 弗·哈夫曼-拉罗切有限公司 表达载体组织、新的生产用细胞产生方法及其在重组产生多肽中的用途
GB2502127A (en) * 2012-05-17 2013-11-20 Kymab Ltd Multivalent antibodies and in vivo methods for their production
JP6224077B2 (ja) * 2012-04-17 2017-11-01 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 改変された核酸を用いてポリペプチドを発現させるための方法
EA035266B1 (ru) * 2014-02-28 2020-05-22 Икнос Сайенсиз Са Экспрессирующие конструкции и способы для отбора клеток-хозяев, экспрессирующих полипептиды
KR20180018659A (ko) * 2015-06-08 2018-02-21 코닝 인코포레이티드 전달이 없는 마이크로엘이디 디스플레이

Also Published As

Publication number Publication date
US20220220500A1 (en) 2022-07-14
CN113993888B (zh) 2026-01-06
AU2020304841B2 (en) 2024-08-15
MX2021015193A (es) 2022-01-18
EP3990484A1 (en) 2022-05-04
JP2023183417A (ja) 2023-12-27
KR20220024954A (ko) 2022-03-03
BR112021025806A2 (pt) 2022-02-08
CA3143803A1 (en) 2020-12-30
WO2020260431A1 (en) 2020-12-30
JP7835713B2 (ja) 2026-03-25
JP2022538178A (ja) 2022-08-31
JP7511591B2 (ja) 2024-07-05
CN113993888A (zh) 2022-01-28
AU2020304841A1 (en) 2021-12-23
KR102900433B1 (ko) 2025-12-15

Similar Documents

Publication Publication Date Title
IL290583A (en) Method for the production of protein-containing foods
PT3873883T (pt) Método de síntese
IL264631A (en) Methods for quantitating individual antibodies from a mixture
HUE071295T2 (hu) Eljárás pH-függõ antitestek elõállítására
HUE071204T2 (hu) Eljárás optikai hatású rétegek elõállítására
PL3750866T3 (pl) Sposób wytwarzania alkoholu z węglowodorów
SI3856436T1 (sl) Način za pridobitev stroškovno ugodnih geometrično zapletenih delov
EP3941944A4 (en) BISPECIFIC CLAUDIN-6 ANTIBODIES
IL281771A (en) Method for selecting neoepitopes
IL280651A (en) Proteogenomic-based method for identifying tumor-specific antigens
IL280064A (en) Method of making an aerosol forming substrate
IL265016B (en) A method for purifying antibodies
SG11202010439VA (en) A method for optimizing antibody expression
EP3763743A4 (en) BISPECIFIC ANTIBODY
IL280621A (en) Method for producing enteric neural precursors
EP4046129C0 (fr) Procédé de fabrication
IL289252A (en) Ep2 antagonist
IL280703A (en) Method for preparing liposomes
PT3766255T (pt) Método para obter informações sobre uma luminária
PL3744752T3 (pl) Sposób wytwarzania niecyklicznych polisiloksanów funkcjonalizowanych alkoksylem
IL286684A (en) Method for additive manufacturing an object
IL280423A (en) A method for identifying intermediates
IL285984A (en) Method for producing influenza ha split vaccine
IL288899A (en) Method for producing dihydroisoxazole
KR102272551B9 (ko) 비수술적 방법에 의한 인간유래 3차원 오거노이드의 제조 방법